184 related articles for article (PubMed ID: 19921645)
1. The phenotypic spectrum of contiguous deletion of CYP21A2 and tenascin XB: quadricuspid aortic valve and other midline defects.
Chen W; Kim MS; Shanbhag S; Arai A; VanRyzin C; McDonnell NB; Merke DP
Am J Med Genet A; 2009 Dec; 149A(12):2803-8. PubMed ID: 19921645
[TBL] [Abstract][Full Text] [Related]
2. Measurement of serum tenascin-X in patients with congenital adrenal hyperplasia at risk for Ehlers-Danlos contiguous gene deletion syndrome CAH-X.
Kolli V; Kim H; Rao H; Lao Q; Gaynor A; Milner JD; Merke DP
BMC Res Notes; 2019 Oct; 12(1):711. PubMed ID: 31666125
[TBL] [Abstract][Full Text] [Related]
3. Tenascin-X haploinsufficiency associated with Ehlers-Danlos syndrome in patients with congenital adrenal hyperplasia.
Merke DP; Chen W; Morissette R; Xu Z; Van Ryzin C; Sachdev V; Hannoush H; Shanbhag SM; Acevedo AT; Nishitani M; Arai AE; McDonnell NB
J Clin Endocrinol Metab; 2013 Feb; 98(2):E379-87. PubMed ID: 23284009
[TBL] [Abstract][Full Text] [Related]
4. A TNXB splice donor site variant as a cause of hypermobility type Ehlers-Danlos syndrome in patients with congenital adrenal hyperplasia.
Lao Q; Mallappa A; Rueda Faucz F; Joyal E; Veeraraghavan P; Chen W; Merke DP
Mol Genet Genomic Med; 2021 Feb; 9(2):e1556. PubMed ID: 33332743
[TBL] [Abstract][Full Text] [Related]
5. Tenascin-X, Congenital Adrenal Hyperplasia, and the CAH-X Syndrome.
Miller WL; Merke DP
Horm Res Paediatr; 2018; 89(5):352-361. PubMed ID: 29734195
[TBL] [Abstract][Full Text] [Related]
6. Salt-wasting congenital adrenal hyperplasia phenotype as a result of the TNXA/TNXB chimera 1 (CAH-X CH-1) and the pathogenic IVS2-13A/C > G in CYP21A2 gene.
Fanis P; Skordis N; Phylactou LA; Neocleous V
Hormones (Athens); 2023 Mar; 22(1):71-77. PubMed ID: 36264454
[TBL] [Abstract][Full Text] [Related]
7. Congenital Adrenal Hyperplasia and Ehlers-Danlos Syndrome.
Marino R; Moresco A; Perez Garrido N; Ramirez P; Belgorosky A
Front Endocrinol (Lausanne); 2022; 13():803226. PubMed ID: 35282436
[TBL] [Abstract][Full Text] [Related]
8. Congenital adrenal hyperplasia with a
Ivo CR; Fitas AL; Madureira I; Diamantino C; Gomes S; Gonçalves J; Lopes L
J Pediatr Endocrinol Metab; 2023 Jan; 36(1):81-85. PubMed ID: 36259452
[TBL] [Abstract][Full Text] [Related]
9. Ehlers-Danlos Syndrome Caused by Biallelic TNXB Variants in Patients with Congenital Adrenal Hyperplasia.
Chen W; Perritt AF; Morissette R; Dreiling JL; Bohn MF; Mallappa A; Xu Z; Quezado M; Merke DP
Hum Mutat; 2016 Sep; 37(9):893-7. PubMed ID: 27297501
[TBL] [Abstract][Full Text] [Related]
10. Ehlers-Danlos Syndrome: Molecular and Clinical Characterization of TNXA/TNXB Chimeras in Congenital Adrenal Hyperplasia.
Marino R; Garrido NP; Ramirez P; Notaristéfano G; Moresco A; Touzon MS; Vaiani E; Finkielstain G; Obregón MG; Balbi V; Soria I; Belgorosky A
J Clin Endocrinol Metab; 2021 Jun; 106(7):e2789-e2802. PubMed ID: 33482002
[TBL] [Abstract][Full Text] [Related]
11. The Prevalence of the Chimeric TNXA/TNXB Gene and Clinical Symptoms of Ehlers-Danlos Syndrome with 21-Hydroxylase Deficiency.
Gao Y; Lu L; Yu B; Mao J; Wang X; Nie M; Wu X
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32291442
[TBL] [Abstract][Full Text] [Related]
12. Broadening the Spectrum of Ehlers Danlos Syndrome in Patients With Congenital Adrenal Hyperplasia.
Morissette R; Chen W; Perritt AF; Dreiling JL; Arai AE; Sachdev V; Hannoush H; Mallappa A; Xu Z; McDonnell NB; Quezado M; Merke DP
J Clin Endocrinol Metab; 2015 Aug; 100(8):E1143-52. PubMed ID: 26075496
[TBL] [Abstract][Full Text] [Related]
13. Pseudogene
Lao Q; Zhou K; Parker M; Faucz FR; Merke DP
Genes (Basel); 2023 Jan; 14(2):. PubMed ID: 36833192
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis and genetic testing strategies for diagnosing 21-hydroxylase deficiency, including CAH-X syndrome.
Kim JH; Kim GH; Yoo HW; Choi JH
Ann Pediatr Endocrinol Metab; 2023 Jun; 28(2):77-86. PubMed ID: 37401054
[TBL] [Abstract][Full Text] [Related]
15. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M
Gene; 2013 Sep; 526(2):239-45. PubMed ID: 23570880
[TBL] [Abstract][Full Text] [Related]
16. Genes and Pseudogenes: Complexity of the RCCX Locus and Disease.
Carrozza C; Foca L; De Paolis E; Concolino P
Front Endocrinol (Lausanne); 2021; 12():709758. PubMed ID: 34394006
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of CAH-X Syndrome in Italian Patients with Congenital Adrenal Hyperplasia (CAH) Due to 21-Hydroxylase Deficiency.
Paragliola RM; Perrucci A; Foca L; Urbani A; Concolino P
J Clin Med; 2022 Jul; 11(13):. PubMed ID: 35807105
[TBL] [Abstract][Full Text] [Related]
18. Carriership of a defective tenascin-X gene in steroid 21-hydroxylase deficiency patients: TNXB -TNXA hybrids in apparent large-scale gene conversions.
Koppens PF; Hoogenboezem T; Degenhart HJ
Hum Mol Genet; 2002 Oct; 11(21):2581-90. PubMed ID: 12354783
[TBL] [Abstract][Full Text] [Related]
19. High-Throughput Screening for CYP21A1P-TNXA/TNXB Chimeric Genes Responsible for Ehlers-Danlos Syndrome in Patients with Congenital Adrenal Hyperplasia.
Lao Q; Brookner B; Merke DP
J Mol Diagn; 2019 Sep; 21(5):924-931. PubMed ID: 31229653
[TBL] [Abstract][Full Text] [Related]
20. CAH-X Syndrome: Genetic and Clinical Profile.
Concolino P; Falhammar H
Mol Diagn Ther; 2022 May; 26(3):293-300. PubMed ID: 35476220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
